News for BIND Therapeutics, Inc. (BIND)

Published at

Jun 15, 2023 12:30 PM

by globenewswire.com

positive

positive

Cerevel Therapeutics Appoints Paul Burgess as Chief Business Development and Strategic Operations Officer

Mr. Burgess will be responsible for leading Cerevel’s business development and quality teams Mr. Burgess to join Cerevel effective June 20, 2023 ...

TBIO BIND

Read more →
Published at

Mar 1, 2023 11:09 PM

by seekingalpha.com

mixed

mixed

Seer Grows Revenue But Losses Increase (NASDAQ:SEER)

Seer went public in December 2020, raising approximately $175 million in a U.S. IPO. Click here to see our take on SEER stock.

SEER SELB BIND

Read more →
Published at

Aug 23, 2021 1:01 PM

by marketscreener.com

mixed

mixed

GT Biopharma : Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical Officer

BEVERLY HILLS, Calif., Aug. 23, 2021 /PRNewswire/ -- GT Biopharma, Inc. , a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's... | August 23, 2021

GTBP CELU VSTM BIND

Read more →